Mesenchymal Stromal Cells for Kidney Repair
Year: 2020
Type: dissertation
Abstract: There is a great demand for transplant kidneys for the treatment of end-stage kidney disease patients.To expand the donor pool, organs from older and comorbid brain death donors, socalled expanded criteria donors (ECD), as well as donation after circulatory death donors, are considered for transplantation.However, the quality of these organs may be inferior to standard donor organs.A major issue affecting graft function and survival is ischemia reperfusion injury, which particularly affects kidneys from deceased donors.The development of hypothermic machine perfusion has been introduced in kidney transplantation as a preservation technique and has improved outcomes in ECD and marginal organs compared to static cold storage.Normothermic machine perfusion is the most recent evolution of perfusion technology and allows assessment of the donor organ prior to transplantation.The possibility to control the content of the perfusion fluid offers opportunities for damage control and reparative therapies during machine perfusion.Mesenchymal stromal cells (MSC) have been demonstrated to possess potent regenerative properties via the release of paracrine effectors.The combination of normothermic machine perfusion and MSC administration at the same time is a promising procedure in the field of transplantation.Therefore, the MePEP consortium has been created to study this novel modality of treatment in preparation for human trials.MePEP aims to assess the therapeutic effects of MSC administered ex-vivo by normothermic machine perfusion in the mechanisms of injury and repair in a porcine kidney autotransplantation model.
Author: Jesús M. Sierra Párraga
Institution: Erasmus University Rotterdam
Language: English
Subfield: Cell Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W3083702658
